← Back to Search

Acceptance and Commitment Therapy for Cystic Fibrosis

N/A

Waitlist Available

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months before study, 3 months after study.

Awards & highlights

Study Summary

This trial will compare the effectiveness of two different types of therapy for adults with Cystic Fibrosis. One is called Acceptance and Commitment Therapy, which helps people learn new ways to manage their experiences and feelings. The other is called Supportive Psychotherapy, which is basically just talking about your experiences with someone. The hypothesis is that the first therapy will lead to better results in terms of medication compliance, overall wellbeing, and coping skills.

Eligible Conditions

Cystic Fibrosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months before study, 3 months after study.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months before study, 3 months after study.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months before study, 3 months after study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptance and Action Questionnaire (AAQ-II)

Beck Anxiety Inventory (BAI)

Beck Depression Inventory-II (BDI-II)

+1 more

Secondary outcome measures

FEV1/ FVC ratio

The Cystic Fibrosis Questionnaire-Revised (CFQ-R)

The Treatment Adherence Questionnaire-CF

Other outcome measures

Generalized Anxiety Disorder Questionnaire 7 (GAD-7)

Patient Health Questionnaire 9 (PHQ-9)

Trial Design

2Treatment groups

Active Control

Group I: Acceptance and Commitment TherapyActive Control1 Intervention

Participants will learn new ways to manage uncomfortable experiences and feelings and to engage in positive behaviors.

Group II: Supportive PsychotherapyActive Control1 Intervention

Participants will talk about their experiences to date.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

445 Previous Clinical Trials

145,568 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available opportunities for participants in this experiment?

"Affirmative. According to the clinicaltrials.gov database, this medical trial is currently accepting participants. This project was first published on July 1st 2019 and has been updated as recently as October 18th 2022; 210 individuals must be enrolled from one centre."

Answered by AI

What are the key aims of this experiment?

"This clinical trial will primarily evaluate patient progress through the Beck Anxiety Inventory, to be assessed at baseline, following 6 weeks of treatment and 3 months after completion. Secondary measures include changes in cognitive fusion as measured by the Cognitive Fusion Questionnaire (CFQ13), acceptance via Acceptance and Action Questionnaire (AAQ-II) and pulmonary function ratio with FEV1/ FVC measurements."

Answered by AI

What is the maximum enrollment capacity of this research project?

"Affirmative, according to the information provided on clinicaltrials.gov this research endeavour has been recruiting since July 1st 2019 and was recently adjusted October 18th 2022. 210 human subjects are needed from a single clinic for participation in this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients

C. Virginia O'Hayer 2019. "Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04114227.